SG Americas Securities’s Atara Biotherapeutics ATRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,189
Closed -$21K 2425
2024
Q1
$21K Sell
1,189
-808
-40% -$14.3K ﹤0.01% 2501
2023
Q4
$26K Buy
1,997
+447
+29% +$5.82K ﹤0.01% 2689
2023
Q3
$57K Buy
+1,550
New +$57K ﹤0.01% 2617
2023
Q2
Sell
-1,388
Closed -$101K 1974
2023
Q1
$101K Buy
1,388
+311
+29% +$22.6K ﹤0.01% 2655
2022
Q4
$88K Sell
1,077
-195
-15% -$15.9K ﹤0.01% 2498
2022
Q3
$120K Sell
1,272
-1,416
-53% -$134K ﹤0.01% 2425
2022
Q2
$524K Sell
2,688
-5,567
-67% -$1.09M 0.01% 1742
2022
Q1
$1.92M Sell
8,255
-479
-5% -$111K 0.01% 819
2021
Q4
$3.44M Sell
8,734
-1,276
-13% -$503K 0.02% 624
2021
Q3
$4.48M Buy
10,010
+2,061
+26% +$922K 0.02% 543
2021
Q2
$3.09M Buy
7,949
+4,823
+154% +$1.87M 0.01% 775
2021
Q1
$1.12M Buy
3,126
+2,559
+451% +$918K 0.01% 1316
2020
Q4
$278K Sell
567
-551
-49% -$270K ﹤0.01% 2131
2020
Q3
$362K Buy
+1,118
New +$362K ﹤0.01% 1532
2020
Q2
Sell
-433
Closed -$92K 3140
2020
Q1
$92K Buy
433
+114
+36% +$24.2K ﹤0.01% 2579
2019
Q4
$131K Buy
+319
New +$131K ﹤0.01% 2401
2019
Q2
Sell
-417
Closed -$415K 2542
2019
Q1
$415K Buy
417
+20
+5% +$19.9K ﹤0.01% 1747
2018
Q4
$345K Buy
397
+292
+278% +$254K ﹤0.01% 1787
2018
Q3
$108K Buy
+105
New +$108K ﹤0.01% 2469
2018
Q2
Sell
-110
Closed -$107K 2775
2018
Q1
$107K Buy
+110
New +$107K ﹤0.01% 2479
2017
Q4
Sell
-342
Closed -$142K 2540
2017
Q3
$142K Buy
+342
New +$142K ﹤0.01% 2526
2017
Q2
Sell
-205
Closed -$105K 2655
2017
Q1
$105K Sell
205
-232
-53% -$119K ﹤0.01% 2624
2016
Q4
$155K Buy
+437
New +$155K ﹤0.01% 2251
2015
Q4
Sell
-190
Closed -$150K 2173
2015
Q3
$150K Buy
+190
New +$150K ﹤0.01% 1627